Arafat Meah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Arafat Meah has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jun Wang
Multiplex Biotechnology Laboratory, Department of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, NY 11794, USA
3 shared publications - Sandeep K. Mallipattu
Division of Nephrology and Hypertension, Department of Medicine, Stony Brook University, Stony Brook, New York, USA; Renal Section, Northport VA Medical Center, Northport, New York, USA
2 shared publications - Meghana Davuluri
Department of Biomedical Engineering, State University of New York at Stony Brook, Stony Brook, NY 11794, USA
1 shared publication - Ming Lin
Department of Computer Science, State University of New York at Stony Brook, Stony Brook, NY 11794, USA
1 shared publication - Monica P. Revelo
University of Utah
1 shared publication Nehaben A. Gujarati
Division of Nephrology and Hypertension, Department of Medicine, Stony Brook School of Medicine, Stony Brook, New York, United States
1 shared publication
Latest Publications
- Open Access
- 15 July 2026
- Published by MDPI AG in Biosensors
- Vol. 16 (7) , 385
Universal, Rapid, and Cleavable Labeling of Antibodies by Fluorophores and DNA Oligonucleotides for Multiplex Immunostaining and Spatial Proteomics Through MIST Linker
Direct antibody labeling is essential for immunoassays, multiplexed imaging, and biosensing; however, current methods are often time-consuming, restricted by antibody source, risk compromising protein performance, or vary with multiple steps. We introduce multiplex in situ tagging (MIST) Linker, a rapid and Fc-site-specific labeling tool that conjugates fluorophores or DNA oligonucleotides to antibodies from diverse commercial sources in as fast as 10 min using minimal starting material. MIST Linker achieves >90% cleavage upon UV exposure, facilitating rapid cyclic imaging on a single specimen. Validated across multiple species and sources, the platform outperforms conventional two-step immunofluorescence and immunohistochemistry in various tissues and cell lines. By enabling the rapid, cost-effective customization of antibody panels, MIST Linker significantly lowers the barrier to accessing antibody–DNA conjugates for spatial biology. When integrated with the spatial MIST platform and MIST-Explorer, it enables high-plex, single-cell spatial proteomics at high signal-to-noise ratios in human clinical biopsies, mouse specimens and cell lines. This toolkit provides an efficient, accessible solution for high-resolution spatial mapping, allowing for the in-depth analysis of cell subpopulations, biomarker distributions, and signaling events in complex biological specimens. Thus, MIST Linker offers a versatile, accessible, and scalable solution for antibody-labeling-based research and clinical diagnosis.
- 15 July 2026
- Published by MDPI AG in Biosensors
- Vol. 16 (7) , 385
Open AccessUniversal, Rapid, and Cleavable Labeling of Antibodies by Fluorophores and DNA Oligonucleotides for Multiplex Immunostaining and Spatial Proteomics Through MIST Linker
Direct antibody labeling is essential for immunoassays, multiplexed imaging, and biosensing; however, current methods are often time-consuming, restricted by antibody source, risk compromising protein performance, or vary with multiple steps. We introduce multiplex in situ tagging (MIST) Linker, a rapid and Fc-site-specific labeling tool that conjugates fluorophores or DNA oligonucleotides to antibodies from diverse commercial sources in as fast as 10 min using minimal starting material. MIST Linker achieves >90% cleavage upon UV exposure, facilitating rapid cyclic imaging on a single specimen. Validated across multiple species and sources, the platform outperforms conventional two-step immunofluorescence and immunohistochemistry in various tissues and cell lines. By enabling the rapid, cost-effective customization of antibody panels, MIST Linker significantly lowers the barrier to accessing antibody–DNA conjugates for spatial biology. When integrated with the spatial MIST platform and MIST-Explorer, it enables high-plex, single-cell spatial proteomics at high signal-to-noise ratios in human clinical biopsies, mouse specimens and cell lines. This toolkit provides an efficient, accessible solution for high-resolution spatial mapping, allowing for the in-depth analysis of cell subpopulations, biomarker distributions, and signaling events in complex biological specimens. Thus, MIST Linker offers a versatile, accessible, and scalable solution for antibody-labeling-based research and clinical diagnosis.
- 1 December 2025
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 329 (6) , F820-F833
Characterization and classification of chronic kidney disease by spatial MIST and deep learning algorithm
In this study, we offer a novel spatial analysis of markers relevant to CKD, which may provide useful insights into disease progression. By using this spatial proximity data, we created a GNN model that is capable of classifying disease severity and identifying markers that are most important for its classification. This integrative approach offers a foundation for future studies aimed at developing clinically actionable tools for CKD diagnosis and prognosis.
- 1 December 2025
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 329 (6) , F820-F833
Characterization and classification of chronic kidney disease by spatial MIST and deep learning algorithm
In this study, we offer a novel spatial analysis of markers relevant to CKD, which may provide useful insights into disease progression. By using this spatial proximity data, we created a GNN model that is capable of classifying disease severity and identifying markers that are most important for its classification. This integrative approach offers a foundation for future studies aimed at developing clinically actionable tools for CKD diagnosis and prognosis.
- Open Access
- 27 August 2023
- Published by MDPI AG in Biosensors
- Vol. 13 (9) , 852
Single-Cell Spatial MIST for Versatile, Scalable Detection of Protein Markers
High-multiplex detection of protein biomarkers across tissue regions has been an attractive spatial biology approach due to significant advantages over traditional immunohistochemistry (IHC) methods. Different from most methods, spatial multiplex in situ tagging (MIST) transfers the spatial protein expression information to an ultrahigh-density, large-scale MIST array. This technique has been optimized to reach single-cell resolution by adoption of smaller array units and 30% 8-arm PEG polymer as transfer medium. Tissue cell nuclei stained with lamin B have been clearly visualized on the MIST arrays and are colocalized with detection of nine mouse brain markers. Pseudocells defined at 10 μm in size have been used to fully profile tissue regions including cells and the intercellular space. We showcased the versatility of our technology by successfully detecting 20 marker proteins in kidney samples with the addition of five minutes atop the duration of standard immunohistochemistry protocols. Spatial MIST is amenable to iterative staining and detection on the same tissue samples. When 25 proteins were co-detected on 1 mouse brain section for each round and 5 rounds were executed, an ultrahigh multiplexity of 125 proteins was obtained for each pseudocell. With its unique abilities, this single-cell spatial MIST technology has the potential to become an important method in advanced diagnosis of complex diseases.
- 27 August 2023
- Published by MDPI AG in Biosensors
- Vol. 13 (9) , 852
Open AccessSingle-Cell Spatial MIST for Versatile, Scalable Detection of Protein Markers
High-multiplex detection of protein biomarkers across tissue regions has been an attractive spatial biology approach due to significant advantages over traditional immunohistochemistry (IHC) methods. Different from most methods, spatial multiplex in situ tagging (MIST) transfers the spatial protein expression information to an ultrahigh-density, large-scale MIST array. This technique has been optimized to reach single-cell resolution by adoption of smaller array units and 30% 8-arm PEG polymer as transfer medium. Tissue cell nuclei stained with lamin B have been clearly visualized on the MIST arrays and are colocalized with detection of nine mouse brain markers. Pseudocells defined at 10 μm in size have been used to fully profile tissue regions including cells and the intercellular space. We showcased the versatility of our technology by successfully detecting 20 marker proteins in kidney samples with the addition of five minutes atop the duration of standard immunohistochemistry protocols. Spatial MIST is amenable to iterative staining and detection on the same tissue samples. When 25 proteins were co-detected on 1 mouse brain section for each round and 5 rounds were executed, an ultrahigh multiplexity of 125 proteins was obtained for each pseudocell. With its unique abilities, this single-cell spatial MIST technology has the potential to become an important method in advanced diagnosis of complex diseases.